plx
pharma
discuss
third
quarter
financial
results
november
conference
call
provide
business
update
sparta
globe
newswire
plx
pharma
nasdaq
plxp
plx
company
specialty
pharmaceutical
company
focused
developing
delivery
system
provide
effective
safer
products
mg
mg
referred
together
vazalore
announced
today
company
release
third
quarter
financial
results
friday
november
financial
markets
open
natasha
giordano
president
chief
executive
officer
rita
connor
chief
financial
officer
host
conference
call
discuss
results
provide
business
update
follows
date
friday
november
time
et
toll
free
international
conference
id
webcast
live
replay
investor
relations
section
replay
conference
call
available
two
weeks
call
completion
dialing
international
conference
id
replay
archived
webcast
available
days
via
aforementioned
url
vazalore
vazalore
mg
aspirin
capsule
provides
patients
vascular
disease
diabetic
patients
candidates
aspirin
therapy
faster
reliable
predictable
platelet
inhibition
compared
aspirin
also
reducing
risk
stomach
erosions
ulcers
compared
aspirin
common
acute
setting
plx
focused
collecting
data
including
results
bioequivalence
study
required
manufacturing
changes
included
snda
filing
vazalore
mg
support
approval
low
dose
vazalore
plx
pharma
plx
pharma
specialty
pharmaceutical
company
focused
developing
clinically
validated
delivery
system
provide
effective
safer
products
plxguard
delivery
system
works
targeting
delivery
active
pharmaceutical
ingredients
various
portions
gastrointestinal
gi
tract
plx
believes
potential
improve
absorption
many
drugs
currently
market
development
reduce
risk
stomach
erosions
ulcers
associated
aspirin
ibuprofen
potentially
drugs
learn
plx
pharma
pipeline
please
visit
contact
investor
relations
lisa
wilson
communications
e
lwilson
